<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02499471</url>
  </required_header>
  <id_info>
    <org_study_id>NL 39146.068.11</org_study_id>
    <nct_id>NCT02499471</nct_id>
  </id_info>
  <brief_title>Brown Adipose Tissue Activity and Thyroid Hormone</brief_title>
  <official_title>Brown Adipose Tissue Activity and Thyroid Hormone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: During the last decades, research in possible therapies for existing obesity and
      developmental factors causing obesity has explosively increased. Recently renewed interest
      aroused for a tissue playing a possible role in both development and therapy for obesity:
      brown adipose tissue (BAT).

      To define the relation between BAT and thyroid hormone, the investigators set up the
      following research protocol. In this protocol BAT activity will be determined in subjects
      that underwent thyroidectomy for well-differentiated thyroid carcinoma.

      Objective: To study the effect of thyroid hormone and thyroid-stimulating hormone on brown
      adipose tissue activity.

      Study design: Determine BAT activity after thyroidectomy in well-differentiated thyroid
      carcinoma patients.

      Study population: Patients that underwent thyroidectomy for well-differentiated thyroid
      carcinoma, male and female, aged 18-65 years.

      Intervention: FDG-PET-CT-imaging ([18F]fluorodeoxyglucose positron-emission-tomography
      computed-tomography) of BAT activity will be performed under cold stimulation twice.

      For patients clinically withdrawn from thyroid hormone suppletion, the first occasion will be
      in a hypothyroid state within 4-6 weeks after thyroidectomy and the second measurement will
      take place in a euthyroid state 4 months after the start of thyroid hormone treatment.

      For patients receiving recombinant-thyroid-stimulating-hormone injections, the first occasion
      will be shortly after the injection in a state of high thyroid-stimulating hormone levels.
      The second measurement will be in a euthyroid state 4 months after the injection.

      Main study parameters/endpoints: The main endpoint of this study is the effect of thyroid
      hormone and thyroid-stimulating hormone on BAT activity in kBq (kilobecquerel) and SUV
      (standard uptake value). Secondary endpoints are the effects of thyroid hormone and
      thyroid-stimulating hormone on energy metabolism, body core temperature, skin surface
      temperatures and skin perfusion.

      Nature and extent of the burden and risks associated with participation, benefit and group
      relatedness: The absorbed radiation dose from the FDG PET-CT scan after administration of 74
      MBq (megabecquerel) of 18F-FDG is 2.8 mSv (miliSievert).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cold-induced brown adipose tissue activity</measure>
    <time_frame>1 day</time_frame>
    <description>Measured with 18FDG PET/CT scan after personalised cooling protocol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>1 day</time_frame>
    <description>Energy expenditure measured with ventilated hood system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body core temperature</measure>
    <time_frame>1 day</time_frame>
    <description>Body core temperature measured with CorTemp telemetric pill</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin temperatures</measure>
    <time_frame>1 day</time_frame>
    <description>Skin temperatures measured with iButton wireless dataloggers at 14 ISO-defined positions on the skin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin perfusion</measure>
    <time_frame>1 day</time_frame>
    <description>Skin perfusion measured with laser-doppler flowmetry on hand and forearm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Hypothyroidism</condition>
  <condition>Hyperthyroidism</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Before levothyroxine therapy 137.75 μg</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>18F-FDG PET CT scan after mild cold exposure 6.8 ± 2.8 weeks after thyroidectomy, when plasma free T4-levels were at the minimum, before daily levothyroxine therapy 137.75 ± 25.75 μg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>After levothyroxine therapy 137.75 μg</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>18F-FDG PET CT scan after mild cold exposure four to six months after the initial measurements, after daily levothyroxine therapy 137.75 μg (fT4 levels 23.1 ± 3.9 pmol/L, TSH 0.5 ± 0.6 mU/L)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Levothyroxine therapy (137.75 ± 23.75 μg/day)</intervention_name>
    <description>This study was a longitudinal study in an academic center, with a follow-up period of 6 months. Ten patients with well-differentiated thyroid carcinoma eligible for surgical treatment and subsequent radioactive iodine ablation therapy were studied in a hypothyroid state after thyroidectomy and in a subclinical hyperthyroid state (TSH-suppression according to standard treatment protocol).</description>
    <arm_group_label>Before levothyroxine therapy 137.75 μg</arm_group_label>
    <arm_group_label>After levothyroxine therapy 137.75 μg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or postmenopausal females undergoing a total thyroidectomy for
             well-differentiated thyroid carcinoma

          -  Age 18-65 years

          -  Stable physical activity levels for at least six months

          -  Note: In case of use of anticoagulation, the dose will be adjusted according to plasma
             thyroid hormone values.

        Exclusion Criteria:

          -  Psychologically unstable subjects (as judged by the treating medical specialist)

          -  Subjects with mental retardation (as judged by the treating medical specialist)

          -  Subjects with severe behavior disorders (as judged by the treating medical specialist)

          -  Pregnant subjects

          -  The use of the following medication is an exclusion criterium; ß-blockers

          -  Participation in an intensive weight-loss program or vigorous exercise program during
             the last year before the start of the study

          -  Abuse of drugs and/or alcohol

          -  Severe diabetes which requires application of insulin or patients with
             diabetes-related complications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wouter van Marken Lichtenbelt, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht UMC</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238-45. Review. Erratum in: JAMA. 2005 Jan 19;293(3):298. JAMA. 2005 Jan 19;293(3):293-4.</citation>
    <PMID>15010446</PMID>
  </reference>
  <reference>
    <citation>van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009 Apr 9;360(15):1500-8. doi: 10.1056/NEJMoa0808718. Erratum in: N Engl J Med. 2009 Apr 30;360(18):1917.</citation>
    <PMID>19357405</PMID>
  </reference>
  <reference>
    <citation>Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerbäck S, Nuutila P. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009 Apr 9;360(15):1518-25. doi: 10.1056/NEJMoa0808949. Erratum in: N Engl J Med. 2009 Sep 10;361(11):1123.</citation>
    <PMID>19357407</PMID>
  </reference>
  <reference>
    <citation>Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004 Jan;84(1):277-359. Review.</citation>
    <PMID>14715917</PMID>
  </reference>
  <reference>
    <citation>Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009 Jul;58(7):1526-31. doi: 10.2337/db09-0530. Epub 2009 Apr 28.</citation>
    <PMID>19401428</PMID>
  </reference>
  <reference>
    <citation>Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerbäck S, Virtanen KA. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 2011 Aug 3;14(2):272-9. doi: 10.1016/j.cmet.2011.06.012.</citation>
    <PMID>21803297</PMID>
  </reference>
  <reference>
    <citation>van der Lans AA, Hoeks J, Brans B, Vijgen GH, Visser MG, Vosselman MJ, Hansen J, Jörgensen JA, Wu J, Mottaghy FM, Schrauwen P, van Marken Lichtenbelt WD. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J Clin Invest. 2013 Aug;123(8):3395-403. doi: 10.1172/JCI68993. Epub 2013 Jul 15.</citation>
    <PMID>23867626</PMID>
  </reference>
  <reference>
    <citation>TATA JR, ERNSTER L, LINDBERG O. Control of basal metabolic rate by thyroid hormones and cellular function. Nature. 1962 Mar 17;193:1058-60.</citation>
    <PMID>13919771</PMID>
  </reference>
  <reference>
    <citation>Goglia F, Silvestri E, Lanni A. Thyroid hormones and mitochondria. Biosci Rep. 2002 Feb;22(1):17-32. Review.</citation>
    <PMID>12418548</PMID>
  </reference>
  <reference>
    <citation>Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002 Feb;23(1):38-89. Review.</citation>
    <PMID>11844744</PMID>
  </reference>
  <reference>
    <citation>Johannsen DL, Galgani JE, Johannsen NM, Zhang Z, Covington JD, Ravussin E. Effect of short-term thyroxine administration on energy metabolism and mitochondrial efficiency in humans. PLoS One. 2012;7(7):e40837. doi: 10.1371/journal.pone.0040837. Epub 2012 Jul 26.</citation>
    <PMID>22844412</PMID>
  </reference>
  <reference>
    <citation>Lee JY, Takahashi N, Yasubuchi M, Kim YI, Hashizaki H, Kim MJ, Sakamoto T, Goto T, Kawada T. Triiodothyronine induces UCP-1 expression and mitochondrial biogenesis in human adipocytes. Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C463-72. doi: 10.1152/ajpcell.00010.2011. Epub 2011 Nov 9.</citation>
    <PMID>22075692</PMID>
  </reference>
  <reference>
    <citation>de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim SW, Harney JW, Larsen PR, Bianco AC. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest. 2001 Nov;108(9):1379-85.</citation>
    <PMID>11696583</PMID>
  </reference>
  <reference>
    <citation>Endo T, Kobayashi T. Thyroid-stimulating hormone receptor in brown adipose tissue is involved in the regulation of thermogenesis. Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E514-8. doi: 10.1152/ajpendo.90433.2008. Epub 2008 Jun 17.</citation>
    <PMID>18559984</PMID>
  </reference>
  <reference>
    <citation>López M, Varela L, Vázquez MJ, Rodríguez-Cuenca S, González CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, Martínez de Morentin PB, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Oresic M, Chatterjee K, Saha AK, Rahmouni K, Diéguez C, Vidal-Puig A. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010 Sep;16(9):1001-8. doi: 10.1038/nm.2207. Epub 2010 Aug 29.</citation>
    <PMID>20802499</PMID>
  </reference>
  <reference>
    <citation>Andersen S, Kleinschmidt K, Hvingel B, Laurberg P. Thyroid hyperactivity with high thyroglobulin in serum despite sufficient iodine intake in chronic cold adaptation in an Arctic Inuit hunter population. Eur J Endocrinol. 2012 Mar;166(3):433-40. doi: 10.1530/EJE-11-0888. Epub 2011 Dec 14.</citation>
    <PMID>22170797</PMID>
  </reference>
  <reference>
    <citation>Louzada RA, Santos MC, Cavalcanti-de-Albuquerque JP, Rangel IF, Ferreira AC, Galina A, Werneck-de-Castro JP, Carvalho DP. Type 2 iodothyronine deiodinase is upregulated in rat slow- and fast-twitch skeletal muscle during cold exposure. Am J Physiol Endocrinol Metab. 2014 Dec 1;307(11):E1020-9. doi: 10.1152/ajpendo.00637.2013. Epub 2014 Oct 7.</citation>
    <PMID>25294216</PMID>
  </reference>
  <reference>
    <citation>Lahesmaa M, Orava J, Schalin-Jäntti C, Soinio M, Hannukainen JC, Noponen T, Kirjavainen A, Iida H, Kudomi N, Enerbäck S, Virtanen KA, Nuutila P. Hyperthyroidism increases brown fat metabolism in humans. J Clin Endocrinol Metab. 2014 Jan;99(1):E28-35. doi: 10.1210/jc.2013-2312. Epub 2013 Dec 20.</citation>
    <PMID>24152690</PMID>
  </reference>
  <reference>
    <citation>van Marken Lichtenbelt WD, Daanen HA, Wouters L, Fronczek R, Raymann RJ, Severens NM, Van Someren EJ. Evaluation of wireless determination of skin temperature using iButtons. Physiol Behav. 2006 Jul 30;88(4-5):489-97. Epub 2006 Jun 23.</citation>
    <PMID>16797616</PMID>
  </reference>
  <reference>
    <citation>Kingma BR, Frijns AJ, Saris WH, van Steenhoven AA, Lichtenbelt WD. Increased systolic blood pressure after mild cold and rewarming: relation to cold-induced thermogenesis and age. Acta Physiol (Oxf). 2011 Dec;203(4):419-27. doi: 10.1111/j.1748-1716.2011.02336.x. Epub 2011 Aug 12.</citation>
    <PMID>21707931</PMID>
  </reference>
  <reference>
    <citation>Vosselman MJ, van der Lans AA, Brans B, Wierts R, van Baak MA, Schrauwen P, van Marken Lichtenbelt WD. Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans. Diabetes. 2012 Dec;61(12):3106-13. doi: 10.2337/db12-0288. Epub 2012 Aug 7.</citation>
    <PMID>22872233</PMID>
  </reference>
  <results_reference>
    <citation>Skarulis MC, Celi FS, Mueller E, Zemskova M, Malek R, Hugendubler L, Cochran C, Solomon J, Chen C, Gorden P. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab. 2010 Jan;95(1):256-62. doi: 10.1210/jc.2009-0543. Epub 2009 Nov 6.</citation>
    <PMID>19897683</PMID>
  </results_reference>
  <results_reference>
    <citation>Danforth E Jr, Burger A. The role of thyroid hormones in the control of energy expenditure. Clin Endocrinol Metab. 1984 Nov;13(3):581-95. Review.</citation>
    <PMID>6391756</PMID>
  </results_reference>
  <results_reference>
    <citation>BARKER SB, KLITGAARD HM. Metabolism of tissues excised from thyroxine-injected rats. Am J Physiol. 1952 Jul;170(1):81-6.</citation>
    <PMID>12985867</PMID>
  </results_reference>
  <results_reference>
    <citation>Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta. 2001 Mar 1;1504(1):82-106. Review.</citation>
    <PMID>11239487</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim MS, Hu HH, Aggabao PC, Geffner ME, Gilsanz V. Presence of brown adipose tissue in an adolescent with severe primary hypothyroidism. J Clin Endocrinol Metab. 2014 Sep;99(9):E1686-90. doi: 10.1210/jc.2014-1343. Epub 2014 Jun 10.</citation>
    <PMID>24915119</PMID>
  </results_reference>
  <results_reference>
    <citation>Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983 Fall;4(4):378-88. Review.</citation>
    <PMID>6317368</PMID>
  </results_reference>
  <results_reference>
    <citation>Castillo M, Hall JA, Correa-Medina M, Ueta C, Kang HW, Cohen DE, Bianco AC. Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes. 2011 Apr;60(4):1082-9. doi: 10.2337/db10-0758. Epub 2011 Feb 18.</citation>
    <PMID>21335378</PMID>
  </results_reference>
  <results_reference>
    <citation>Silva JE, Bianco SD. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008 Feb;18(2):157-65. doi: 10.1089/thy.2007.0252. Review.</citation>
    <PMID>18279016</PMID>
  </results_reference>
  <results_reference>
    <citation>Völzke H, Alte D, Dörr M, Wallaschofski H, John U, Felix SB, Rettig R. The association between subclinical hyperthyroidism and blood pressure in a population-based study. J Hypertens. 2006 Oct;24(10):1947-53.</citation>
    <PMID>16957553</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y, Chen Y, Li M, Liu H, Li C, Xue H, Li N, Yu J, Shi L, Bai X, Hou X, Zhu L, Lu L, Wang S, Xing Q, Teng W. A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens. 2010 Feb;24(2):134-8. doi: 10.1038/jhh.2009.44. Epub 2009 Jun 25.</citation>
    <PMID>19554027</PMID>
  </results_reference>
  <results_reference>
    <citation>Thrush AB, Gagnon A, Sorisky A. PKC activation is required for TSH-mediated lipolysis via perilipin activation. Horm Metab Res. 2012 Oct;44(11):825-31. doi: 10.1055/s-0032-1316332. Epub 2012 Jun 22.</citation>
    <PMID>22730012</PMID>
  </results_reference>
  <results_reference>
    <citation>Gagnon A, Antunes TT, Ly T, Pongsuwan P, Gavin C, Lochnan HA, Sorisky A. Thyroid-stimulating hormone stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo. Metabolism. 2010 Apr;59(4):547-53. doi: 10.1016/j.metabol.2009.08.018. Epub 2009 Oct 20.</citation>
    <PMID>19846175</PMID>
  </results_reference>
  <results_reference>
    <citation>Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Weller H, Waurisch C, Eychmüller A, Gordts PL, Rinninger F, Bruegelmann K, Freund B, Nielsen P, Merkel M, Heeren J. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011 Feb;17(2):200-5. doi: 10.1038/nm.2297. Epub 2011 Jan 23.</citation>
    <PMID>21258337</PMID>
  </results_reference>
  <results_reference>
    <citation>Cannon B, Nedergaard J. Thyroid hormones: igniting brown fat via the brain. Nat Med. 2010 Sep;16(9):965-7. doi: 10.1038/nm0910-965.</citation>
    <PMID>20823876</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2015</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
    <mesh_term>Hyperthyroidism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

